Sanofi escapes €116 million damages claim in France
A French court has dismissed as time-barred a follow-on damages claim against Sanofi, as the claimant’s role in the competition authority’s investigation showed it knew about the drugmaker’s illegal conduct before an infringement decision was issued.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10